SE8200748L - Terapeutiskt medel - Google Patents

Terapeutiskt medel

Info

Publication number
SE8200748L
SE8200748L SE8200748A SE8200748A SE8200748L SE 8200748 L SE8200748 L SE 8200748L SE 8200748 A SE8200748 A SE 8200748A SE 8200748 A SE8200748 A SE 8200748A SE 8200748 L SE8200748 L SE 8200748L
Authority
SE
Sweden
Prior art keywords
acid protease
therapeutic agent
tumors
treatment
immune complex
Prior art date
Application number
SE8200748A
Other languages
Unknown language ( )
English (en)
Other versions
SE455163B (sv
Inventor
H Ohnishi
H Kosuzume
Y Suzuki
E Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56018429A external-priority patent/JPS57131725A/ja
Priority claimed from JP56086147A external-priority patent/JPS57206623A/ja
Priority claimed from JP56112856A external-priority patent/JPS5813523A/ja
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of SE8200748L publication Critical patent/SE8200748L/sv
Publication of SE455163B publication Critical patent/SE455163B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8200748A 1981-02-10 1982-02-09 Uropepsin for anvendning som terapeutikum mot allergiska sjukdomar, immunkomplexsjukdomar och tumorer SE455163B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP56018429A JPS57131725A (en) 1981-02-10 1981-02-10 Remedy for immune complex disease
JP56086147A JPS57206623A (en) 1981-06-04 1981-06-04 Remedy for allergic disease
JP56112856A JPS5813523A (ja) 1981-07-18 1981-07-18 抗腫瘍作用を有する医薬組成物

Publications (2)

Publication Number Publication Date
SE8200748L true SE8200748L (sv) 1982-08-11
SE455163B SE455163B (sv) 1988-06-27

Family

ID=27282204

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8200748A SE455163B (sv) 1981-02-10 1982-02-09 Uropepsin for anvendning som terapeutikum mot allergiska sjukdomar, immunkomplexsjukdomar och tumorer

Country Status (11)

Country Link
US (1) US4540569A (sv)
EP (1) EP0059346B1 (sv)
AU (1) AU531314B2 (sv)
CA (1) CA1181005A (sv)
CH (1) CH653557A5 (sv)
DE (2) DE3204631A1 (sv)
FR (1) FR2499409A1 (sv)
GB (1) GB2095993B (sv)
IT (1) IT1154280B (sv)
NL (1) NL8200509A (sv)
SE (1) SE455163B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8083682A (en) * 1982-02-09 1983-08-25 Mochida Pharmaceutical Co., Ltd. Agent for treating allergic disease, immunuty complex diseaseand tumor
JPS5995221A (ja) * 1982-11-20 1984-06-01 Mochida Pharmaceut Co Ltd 食細胞機能調節作用を有する医薬組成物
JP2700088B2 (ja) * 1991-07-25 1998-01-19 房則 濱島 免疫抑制剤
US5914141A (en) * 1997-03-11 1999-06-22 Alfacel S.A. Easy peeling wiener casings via use of enzymes
MY130475A (en) * 2000-08-25 2007-06-29 Contura As Polyacrylamide hydrogel and its use as an endoprosthesis
US20040007251A1 (en) * 2002-07-10 2004-01-15 Kimberly-Clark Worldwide, Inc. Cleaners for the control and removal of allergens

Also Published As

Publication number Publication date
NL8200509A (nl) 1982-09-01
EP0059346A3 (en) 1983-02-09
AU531314B2 (en) 1983-08-18
EP0059346B1 (en) 1986-10-29
DE3273953D1 (en) 1986-12-04
DE3204631A1 (de) 1982-10-07
IT8247761A0 (it) 1982-02-10
SE455163B (sv) 1988-06-27
IT1154280B (it) 1987-01-21
FR2499409A1 (fr) 1982-08-13
EP0059346A2 (en) 1982-09-08
CH653557A5 (de) 1986-01-15
CA1181005A (en) 1985-01-15
GB2095993A (en) 1982-10-13
GB2095993B (en) 1984-08-01
US4540569A (en) 1985-09-10
FR2499409B1 (sv) 1984-01-06
AU8029082A (en) 1982-08-19

Similar Documents

Publication Publication Date Title
EA200401473A1 (ru) Предотвращение и лечение амилоидогенного заболевания
ATE4168T1 (de) 2-phenyl-1,2-benzisoselenazol-3(2h)-one enthaltende pharmazeutische zubereitungen und ihre anwendung.
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
NO157145C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-glykosylerte karboksylsyreamidderivater.
EA200501023A1 (ru) Терапевтические составы для лечения болезней, связанных с наличием бета-амилоида
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DK209088D0 (da) Medicinpraeparater, deres fremstilling og anvendelse
NO158741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere.
EP0249735A3 (en) Pharmaceutical preparations comprising as active agent 2-phenyl-1.2-benzisoselenazol-3(2h)-one, for the treatment of diseases caused by oxidative stress
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
ATE179333T1 (de) Immunotherapeutische zubereitung
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
EE9900428A (et) Köhavastased ravimkoostised
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
SE8200748L (sv) Terapeutiskt medel
DK1343472T3 (da) Thixotropisk næsespray
IT1245717B (it) Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
WO1996032134A3 (de) Konjugat aus einem wirkstoff, einem polyether und ggf. einem nicht als körperfremd angesehenen, nativen protein
SE8303729D0 (sv) Terapeutiskt medel for behandling av allergiska sjukdomstillstand, immunkomplexsjukdomar och tumorer
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
DK0820308T3 (da) Konjugat til behandling af inflammatoriske sygdomme
NO161494C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive benzodiazepiner.
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
ATE139702T1 (de) Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8200748-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8200748-5

Format of ref document f/p: F